Biotech corporations can’t patent cancer-causing genes, Australian court rules

‘A ruling by Australia’s highest court stating that a gene is not a “patentable invention” comes as a huge victory for those who have long awaited such a decision. The ruling specifically zeroes in on BRCA1, a gene associated with an increased risk of breast and ovarian cancer; a United States biotech company, Myriad Genetics; and Australian resident Yvonne D’Arcy.

D’Arcy decided to fight the system in an attempt to prevent Myriad Genetics from patenting mutations in the gene. While lower courts twice shunned her request, the High Court of Australia ultimately slammed the gavel down on the biotech company. The decision means that the company can’t go on with their monopoly mentality and charge about $3,000 for their own tests while bullying those with more affordable cancer testing alternatives out of the picture.’

Read more: Biotech corporations can’t patent cancer-causing genes, Australian court rules

The post Biotech corporations can’t patent cancer-causing genes, Australian court rules appeared first on David Icke.